Valaciclovir Actavis 1000

Држава: Нови Зеланд

Језик: Енглески

Извор: Medsafe (Medicines Safety Authority)

Купи Сада

Активни састојак:

Valaciclovir hydrochloride monohydrate 1223.4mg equivalent to valaciclovir base 1000 mg

Доступно од:

Teva Pharma (New Zealand) Limited

INN (Међународно име):

Valaciclovir hydrochloride monohydrate 1223.4 mg (equivalent to valaciclovir base 1000 mg)

Дозирање:

1000 mg

Фармацеутски облик:

Film coated tablet

Састав:

Active: Valaciclovir hydrochloride monohydrate 1223.4mg equivalent to valaciclovir base 1000 mg Excipient: Magnesium stearate Microcrystalline cellulose Opadry white Y-5-7068 Povidone

Јединице у пакету:

Blister pack, PVC/Al, 7 tablets

Класа:

Prescription

Тип рецептора:

Prescription

Произведен од:

Mylan Laboratories Limited

Терапеутске индикације:

Valaciclovir Actavis is indicated for the treatment of herpes zoster (shingles) and the reduction of zoster - associated pain, which includes acute and post herpetic neuralgia, when given to immunocompetent patients in infection of less than 72 hours duration.

Резиме производа:

Package - Contents - Shelf Life: Blister pack, PVC/Al - 7 tablets - 24 months from date of manufacture stored at or below 25°C - Blister pack, PVC/Al - 14 tablets - 24 months from date of manufacture stored at or below 25°C - Blister pack, PVC/Al - 21 tablets - 24 months from date of manufacture stored at or below 25°C - Blister pack, PVC/Al - 28 tablets - 24 months from date of manufacture stored at or below 25°C - Blister pack, PVC/Al - 56 tablets - 24 months from date of manufacture stored at or below 25°C

Датум одобрења:

2013-02-01

Обавештења о претрази у вези са овим производом

Погледајте историју докумената